Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7303 p728
12 June 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Association of the European Self-Medication Industry: reports (more)


UK health department backs PAGB project to test self-care in one primary care trust

Government backing has been given to a Proprietary Association of Great Britain project to test the effectiveness of self-care.

Erewash Primary Care Trust will soon implement a three-part study designed to show the benefits of a PCT-wide approach to self-care in the prevention of coronary heart disease (CHD), the management of minor ailments and managing asthma. News of the project was leaked at the AESGP meeting.

Mike Pringle, professor of general practice at the University of Nottingham, said that the PCT is funding the scheme locally and the Department of Health is to pay for the project evaluation. The scheme is currently awaiting final ethics committee approval and a report of the outcome of the project is expected by 2006.

The project will involve health information campaigns, with input from pharmacists, doctors, nurses and other health professionals. Community centres, GP surgeries, public houses, clubs, schools and playgroups will be among the locations used to promote self-care in the three study areas.

Outcome measures will include determination of people’s understanding of CHD risk factors and lifestyle changes, such as giving up smoking or taking more exercise. Outcome measures for the minor ailments arm of the study will include changes to GP consultations, antibiotic prescribing and people’s self-care confidence levels. The asthma study will look at the impact of lay-led expert sessions, treatment compliance and health-seeking behaviour.

Professor Pringle said: “As a GP, I can see we must start to break down the belief that doctors do things to patients and that outcomes are the responsibility of health systems, doctors and nurses. Decision-making should rest with the people who live with the results. We should be supportive and available, but not take over.”

The Journal’s attendance at the Association of the European Self-Medication Industry annual meeting in Madrid from 2 to 4 June was made possible by the Proprietary Association of Great Britain

Back to Top


©The Pharmaceutical Journal